04/12/2024
7:44 AM | Notable Labs, Ltd. (Filer)
Notable Labs (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/11/2024
4:00 PM | Notable Labs, Ltd. (Filer)
Notable Labs (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
04/09/2024
4:20 PM | Notable Labs, Ltd. (Filer)
Notable Labs (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/08/2024
11:15 AM | Notable Labs, Ltd. (Filer)
Notable Labs (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/01/2024
3:30 PM | Notable Labs, Ltd. (Filer)
Notable Labs (Filer)
| Form NT 10-K | |
03/25/2024
8:00 AM | Notable Labs, Ltd. (Filer)
Notable Labs (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/22/2024
7:15 AM | Notable Labs, Ltd. (Filer)
Notable Labs (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
02/16/2024
8:00 AM | Notable Labs, Ltd. (Filer)
Notable Labs (Filer)
| Form DEF 14A | |
02/05/2024
4:00 PM | Notable Labs, Ltd. (Filer)
Notable Labs (Filer)
| Form PRE 14A | |
01/11/2024
4:22 PM | FR Capital Holdings, L.P. (Filed by)
Notable Labs, Ltd. (Subject)
Notable Labs (Subject)
| Form SC 13G/A | |
01/08/2024
3:21 PM | Notable Labs, Ltd. (Filer)
Notable Labs (Filer)
| Form RW | |
01/02/2024
4:00 PM | FR Capital Holdings, L.P. (Reporting)
Notable Labs, Ltd. (Issuer)
Notable Labs (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/28/2023
4:00 PM | FR Capital Holdings, L.P. (Reporting)
Notable Labs, Ltd. (Issuer)
Notable Labs (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2023
4:00 PM | FR Capital Holdings, L.P. (Reporting)
Notable Labs, Ltd. (Issuer)
Notable Labs (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2023
7:15 AM | Notable Labs, Ltd. (Filer)
Notable Labs (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/29/2023
4:15 PM | Notable Labs, Ltd. (Filer)
Notable Labs (Filer)
| Form 8-K/A | |
11/29/2023
4:00 PM | Notable Labs, Ltd. (Filer)
Notable Labs (Filer)
| Form 8-K/A | |
10/26/2023
4:15 PM | FR Capital Holdings, L.P. (Filed by)
Notable Labs, Ltd. (Subject)
Notable Labs (Subject)
| Form SC 13G | |
10/26/2023
4:15 PM | FR Capital Holdings, L.P. (Reporting)
Notable Labs, Ltd. (Issuer)
Notable Labs (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/20/2023
8:00 AM | Notable Labs, Ltd. (Filer)
Notable Labs (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/19/2023
12:31 PM | Builders VC Entrepreneurs Fund I, L.P. (Reporting)
Builders VC Fund I , L.P. (0001757197) (Reporting)
Builders VC Fund I, L.P. (Reporting)
KIM JAMES JIMIN (Reporting)
Notable Labs, Ltd. (Issuer)
Notable Labs (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/19/2023
12:34 PM | Builders VC Fund I , L.P. (0001757197) (Filed by)
Notable Labs, Ltd. (Subject)
Notable Labs (Subject)
| Form SC 13D | |
10/18/2023
7:35 AM | McPherson Scott Alan (Reporting)
Notable Labs, Ltd. (Issuer)
Notable Labs (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/18/2023
7:35 AM | Feinberg Peter (Reporting)
Notable Labs, Ltd. (Issuer)
Notable Labs (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/18/2023
7:36 AM | Galen Michele (Reporting)
Notable Labs, Ltd. (Issuer)
Notable Labs (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/18/2023
7:36 AM | Notable Labs, Ltd. (Issuer)
Notable Labs (Issuer)
Wagner Joseph P (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/18/2023
7:36 AM | Notable Labs, Ltd. (Issuer)
Notable Labs (Issuer)
Patsi Tuomo (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/18/2023
7:37 AM | Bock Thomas (Reporting)
Notable Labs, Ltd. (Issuer)
Notable Labs (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/18/2023
7:40 AM | DUBIN THOMAS I H (Reporting)
Notable Labs, Ltd. (Issuer)
Notable Labs (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/18/2023
7:27 AM | Graney Thomas (Reporting)
Notable Labs, Ltd. (Issuer)
Notable Labs (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/17/2023
7:00 AM | Notable Labs, Ltd. (Filer)
Notable Labs (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/16/2023
3:05 PM | Notable Labs, Ltd. (Filer)
Notable Labs (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/12/2023
3:26 PM | Vascular Biogenics Ltd. (Filer)
Notable Labs (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/10/2023
7:00 AM | Vascular Biogenics Ltd. (Filer)
Notable Labs (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/10/2023
7:01 AM | Vascular Biogenics Ltd. (Subject)
Notable Labs (Subject)
| Form 425 | |
10/04/2023
3:33 PM | Vascular Biogenics Ltd. (Subject)
Notable Labs (Subject)
| Form 425 | |
10/02/2023
4:29 PM | Vascular Biogenics Ltd. (Filer)
Notable Labs (Filer)
| Form 424B3 | |
10/02/2023
4:30 PM | Vascular Biogenics Ltd. (Filer)
Notable Labs (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/18/2023
4:21 PM | Vascular Biogenics Ltd. (Filer)
Notable Labs (Filer)
| Form 424B3 | |
09/18/2023
4:27 PM | Vascular Biogenics Ltd. (Filer)
Notable Labs (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/18/2023
4:27 PM | Vascular Biogenics Ltd. (Subject)
Notable Labs (Subject)
| Form 425 | |
The Hard Truth About Investing For Retirement (Ad) Here’s the cold, hard truth about investing:
The more capital you have, the more risk averse you can afford to be.
But when you’re staring down the barrel of retirement and you’ve only got 5, 10, 50 or $100,000 saved, you’ve got to be more aggressive.
In an exclusive online training, the Market expert Steven Place is revealing a powerful “roadmap” that’s leading everyday investors to easy, triple-digit wins, even if they don’t have a lot of experience in trading. Click To Access This Powerful Training Right Now! |
09/06/2023
7:13 AM | Vascular Biogenics Ltd. (Filer)
Notable Labs (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/06/2023
7:17 AM | Vascular Biogenics Ltd. (Subject)
Notable Labs (Subject)
| Form 425 | |
09/05/2023
11:15 PM | Vascular Biogenics Ltd. (Filer)
Notable Labs (Filer)
| Form EFFECT | |
09/01/2023
4:01 PM | Vascular Biogenics Ltd. (Filer)
Notable Labs (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/01/2023
4:06 PM | Vascular Biogenics Ltd. (Subject)
Notable Labs (Subject)
| Form 425 | |
09/01/2023
4:13 PM | Vascular Biogenics Ltd. (Filer)
Notable Labs (Filer)
| Form S-4/A | |
08/23/2023
4:06 PM | Vascular Biogenics Ltd. (Filer)
Notable Labs (Filer)
| Form S-4/A | |
08/14/2023
7:05 AM | Vascular Biogenics Ltd. (Filer)
Notable Labs (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2023
7:06 AM | Vascular Biogenics Ltd. (Subject)
Notable Labs (Subject)
| Form 425 | |
08/14/2023
7:10 AM | Vascular Biogenics Ltd. (Filer)
Notable Labs (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
06/30/2023
3:38 PM | Vascular Biogenics Ltd. (Filer)
Notable Labs (Filer)
| Form S-4/A | |
06/09/2023
3:31 PM | Vascular Biogenics Ltd. (Subject)
Notable Labs (Subject)
| Form 425 | |
05/17/2023
3:54 PM | Vascular Biogenics Ltd. (Subject)
Notable Labs (Subject)
| Form 425 | |
05/11/2023
8:09 AM | Vascular Biogenics Ltd. (Filer)
Notable Labs (Filer)
| Form S-4
Registration statement under Securities Act of 1933 | |
